A-Alpha Bio raises $2.8m to solve ‘major problems’ in early-stage drug development: CEO 25-Sep-2019 By Melissa Fassbender A-Alpha Bio raises $2.8m from venture capital firms and angel investors to further develop its technology – and initiate drug discovery and optimization partnerships with pharmaceutical companies.